
Kura Oncology
Biotechnology • San Diego, CA
About Kura Oncology
Kura Oncology is a clinical-stage biopharmaceutical company that develops precision medicines for the treatment of cancer. Its lead candidate is ziftomenib, a menin inhibitor for NPM1-mutant and KMT2A-rearranged acute myeloid leukemia. The company is also developing tipifarnib, a farnesyltransferase inhibitor, and aims to bring targeted therapies to cancer patients.
Company Information
Open Positions

Associate Director, Medical & Regulatory Writing
Biotechnology
Remote, ; Boston, MA
Full-Time
Remote, US); Boston, MA
Full-Time

